Celldex Therapeutics Inc
NASDAQ: CLDX
$26.22
-$0.18 (-0.7%)
Closing Price on November 21, 2024
CLDX Stock Chart and Intraday Price
CLDX Stock Data
| Asset Type | Stock |
| Exchange | NASDAQ |
| Currency | USD |
| Country | USA |
| Sector | LIFE SCIENCES |
| Industry | IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES |
| Address | 53 FRONTAGE ROAD, SUITE 220, HAMPTON, NJ, US |
| Fiscal Year End | December |
| Latest Quarter | 12/31/2023 |
| Market Cap | 2,900.13M USD |
| Shares Outstanding | 55,901,000 |
CLDX Articles
Monday’s top analyst upgrades and downgrades included American Express, Capital One, Levi Strauss, Pinterest, Peloton, Synchrony and T-Mobile.
Published:
Here, 24/7 Wall St. has included a calendar of some of the biggest companies expecting clinical trial and U.S. Food and Drug Administration (FDA) updates in February and March.
Published:
Last Updated:
Ambev, Renren, Celldex, and Yatra Online all posted new 52-week lows Friday.
Published:
Last Updated:
General Electric, Starbucks, General Dynamics, and Celldex all posted new 52-week lows Thursday.
Published:
Last Updated:
Oracle, Starbucks, Helios and Matheson, and Celldex all posted new 52-week lows Wednesday.
Published:
Last Updated:
Banco Bradesco, Gogo, Tesaro, and Celldex all posted new 52-week lows Wednesday.
Published:
Last Updated:
J.C. Penney, Helios and Matheson, Celldex, and Spectra Energy Partners all posted new 52-week lows Tuesday.
Published:
Last Updated:
MGIC Investment Group, Celldex Therapeutics, Juniper Networks, and Healthcare Services Group all posted new 52-week lows on Wednesday.
Published:
Last Updated:
Celldex Therapeutics, Acacia Communications, Apricus Biosciences, and Ctrp.com all posted new 52-week lows Monday.
Published:
Last Updated:
Celldex Therapeutics shares were absolutely crushed on Monday morning after the firm announced results to its midstage breast cancer study.
Published:
Last Updated:
Jefferies has compiled a list of over 30 biotech events taking place in 2018 that could result in significant stock moves. Some stocks have the potential to double or even crater, should a study be...
Published:
Last Updated:
The top analyst upgrades, downgrades and other research calls include American Airlines, Boeing, Cabot Oil & Gas, Pandora Media, Southern Co. and Vertex Pharmaceuticals.
Published:
Last Updated:
Macy's, Tegna, Celldex, and DryShips posted new 52-week lows Tuesday.
Published:
Last Updated:
Celldex Therapeutics was another big mover coming out of the Annual Meeting for the American Society of Clinical Oncology (ASCO). Unfortunately, the move was to the downside.
Published:
Last Updated:
24/7 Wall St. has collected several big FDA decisions and mid-stage to late-stage trials that should be announced in October.
Published:
Last Updated: